Pre-IPO Review
Aggregating reviews, news, and community signal on pre-IPO companies
Companies
English
中文
Sign in
← Back
Colossal Biosciences
🧬 BCI/Biotech
De-extinction and species preservation through gene editing — mammoth, thylacine, dodo
De-extinction
CRISPR
Conservation
$10.2B
Latest valuation
👀 0
💬 0
⭐ Bookmark
Valuation
$10.2B
Total Funding
$435M+
Founded
2021
HQ
Dallas, TX
📊 View full data on Sacra →
📰 Company News
Colossal Biosciences Advances Woolly Mammoth De-Extinction Project
via Inside the Magic
·
2026-08-09
↗
Colossal Biosciences Creates Male Dire Wolf Named Romulus
via The Daily News | Texas' Oldest Newspaper
·
2026-08-08
↗
Colossal Biosciences invests $100 million to resurrect bluebuck antelope
via Daily Maverick
·
2026-08-06
↗
Show 7 more
🤝 Related Companies
Neuralink
$9.65B
👀 0
💬 1
Isomorphic Labs
$5B
👀 0
💬 0
Altos Labs
$3B
👀 0
💬 0
Insitro
$2.57B
👀 0
💬 0
Generate Biomedicines
$2B
👀 0
💬 0
Xaira Therapeutics
$2B
👀 0
💬 0
📰 Articles
Sign in to submit
No articles yet. Be the first to share one.
Reviews (0)
Sign in to write a review
🔥 Most Helpful
🕐 Newest
No reviews yet. Be the first.